GENE LOSS IN HUMAN TERATOMAS | Zendy

David H. Linder | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

GENE LOSS IN HUMAN TERATOMAS

Author(s) -

David H. Linder

Publication year - 1969

Publication title -

proceedings of the national academy of sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.011

H-Index - 771

eISSN - 1091-6490

pISSN - 0027-8424

DOI - 10.1073/pnas.63.3.699

Subject(s) - phosphoglucomutase , biology , isozyme , locus (genetics) , allele , genetics , meiosis , gene , teratoma , ovary , germ cell , heterozygote advantage , pathology , enzyme , biochemistry , medicine

If benign cystic teratomas (dermoid cysts) of the ovary arise from a germ cell that has undergone meiosis, they should be missing genes which are present in the person. Three independently segregating allelic isozymes in 11 benign cystic teratomas of the human female ovary were compared with normal tissue of the same case. Dermoid cysts from persons heterozygous for these isozymes are frequently homozygous for that particular gene product. One of two dermoid cysts is homozygous for glucose-6-phosphate dehydrogenase, two of four tumors are homozygous for phosphoglucomutase at the PGM(1) locus, and two (or more) of eight tumors are homozygous for phosphoglucomutase at the PGM(3) locus in women heterozygous for these allelic isozymes. These findings are consistent with the hypothesis that these tumors arise from a germ cell which has undergone meiosis with varying degrees of crossing-over.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research